-
Indoco Remedies Standalone September 2025 Net Sales at Rs 442.12 crore, up 11.5% Y-o-Y
-
Indoco Remedies Consolidated September 2025 Net Sales at Rs 484.67 crore, up 12.02% Y-o-Y
-
Hold Indoco Remedies; target of Rs 325: Prabhudas Lilladher
Prabhudas Lilladher recommended hold rating on Indoco Remedies with a target price of Rs 325 in its research report dated July 25, 2025.
-
Indoco Remedies Consolidated June 2025 Net Sales at Rs 437.89 crore, up 1.48% Y-o-Y
-
Indoco Remedies Standalone June 2025 Net Sales at Rs 392.53 crore, down 2.22% Y-o-Y
-
Gainers & Losers: Top 10 stocks that moved the most on June 3
At close, the Sensex was down 636.24 points or 0.78 percent at 80,737.51, and the Nifty was down 174.10 points or 0.70 percent at 24,542.50. About 1,701 shares advanced, 2,148 shares declined, and 134 shares remained unchanged.
-
Indoco Remedies Consolidated March 2025 Net Sales at Rs 390.21 crore, down 13.22% Y-o-Y
-
Indoco Remedies Standalone March 2025 Net Sales at Rs 347.25 crore, down 22.05% Y-o-Y
-
Stocks To Watch: IndusInd, Hindustan Zinc, BEL, NLC India & More | March 11
Let's catch up on the latest stock market updates! IndusInd Bank has identified discrepancies in its derivative portfolio following an internal review. Hindustan Zinc has approved the issuance of ₹500 crore in non-convertible debentures. Ashoka Buildcon has secured a ₹311.92 crore turnkey project in Maharashtra, while MSTC has been awarded a two-year contract by Coal India for e-auction services. Indoco Remedies’ Hyderabad-based research unit recently underwent a USFDA inspection. NLC India’s board has given in-principle approval for a $200 million external commercial borrowing in Japanese Yen. Meanwhile, Bharat Electronics has secured fresh defence orders worth ₹843 crore, bringing its total order book for FY25 to ₹14,567 crore. Stay tuned for a detailed breakdown of these stock market movers!
-
Stocks to Watch Today: IndusInd Bank, Hitachi Energy, NTPC, Syngene, MSTC, HEG, Anupam Rasayan, Nectar Life, Indoco Remedies in focus on 11 March
Stocks to Watch, Mar 11: Stocks like Centum Electronics, NTPC Green Energy, Indian Bank, Urja Global, Bharat Electronics, NLC India, Ashoka Buildcon, Hisar Metal Industries, Anupam Rasayan India, Emcure Pharmaceuticals, Gensol Engineering, and Thermax will be in focus on March 11.
-
Hold Indoco Remedies; target of Rs 325: Prabhudas Lilladher
Prabhudas Lilladher recommended hold rating on Indoco Remedies with a target price of Rs 325 in its research report dated January 22, 2025.
-
Indoco Remedies Consolidated December 2024 Net Sales at Rs 410.55 crore, down 10.64% Y-o-Y
-
Indoco Remedies Standalone December 2024 Net Sales at Rs 372.98 crore, down 16.94% Y-o-Y
-
Indoco Remedies shares fall after USFDA warning letter over Goa facility
Indoco Remedies said it is in touch with the regulator regarding matter. "We will work with the USFDA to resolve these issues at the earliest," Indoco added.
-
Stock Radar: Swiggy, Wipro, Indegene, Protean eGov Tec, Solar Industries, Pricol, Godavari Biorefineries, KPI Green Energy in focus on Tuesday
Stocks like Torrent Power, HCL Technologies, MOIL, LKP Finance, Bharat Petroleum Corporation, TVS Motor Company, Indoco Remedies, Hindustan Unilever, Nazara Technologies, IRFC, and Allcargo Logistics will also be in focus on December 3.
-
Accumulate Indoco Remedies; target of Rs 320 Prabhudas Lilladher
Prabhudas Lilladher recommended accumulate rating on Indoco Remedies with a target price of Rs 320 in its research report dated October 24, 2024.
-
Indoco Remedies Consolidated September 2024 Net Sales at Rs 432.66 crore, down 10.19% Y-o-Y
-
Indoco Remedies Standalone September 2024 Net Sales at Rs 396.53 crore, down 16.24% Y-o-Y
-
Stock Radar: PNC Infratech, JSW Energy, Valore Estate, Metropolis, Ashoka Buildcon, Hindustan Aeronautics in focus on Monday
Stocks like Avenue Supermarts, Hathway Cable and Datacom, Sula Vineyards, Adani Ports and Special Economic Zone, IL&FS Transportation Networks, Tega Industries, JSW Infrastructure, and Indoco Remedies will be in focus on October 14.
-
Trade Spotlight: How should you trade DMart, Apollo Tyres, Indoco Remedies, Piramal Pharma, HPCL and others on Thursday?
The Nifty 50 may rebound after this minor correction, although consolidation appears to be ongoing. Below are some trading ideas for the near term.
-
Accumulate Indoco Remedies; target of Rs 320: Prabhudas Lilladher
Prabhudas Lilladher recommended accumulate rating on Indoco Remedies with a target price of Rs 320 in its research report dated July 25, 2024.
-
Indoco Remedies Standalone June 2024 Net Sales at Rs 401.43 crore, down 5.07% Y-o-Y
-
Indoco Remedies Consolidated June 2024 Net Sales at Rs 431.49 crore, up 1.17% Y-o-Y
-
Indoco Remedies shares gain on final USFDA approval for Pregabalin capsules
The share touched a 52-week high of Rs 416.95 and a 52-week low of Rs 308.80 on January 1, 2024, and October 26, 2023, respectively.
-
Stock Radar: BHEL, PI Industries, Metropolis, Sheela Foam, PNC Infratech, Biocon in focus on Wednesday
Grasim Industries, Sun Pharma, Power Grid Corporation, Paytm, Nykaa, Ashoka Buildcon, Dhanlaxmi Bank, GE Power India, Gland Pharma, GMM Pfaudler, HEG, Jubilant FoodWorks, New India Assurance Company, and Unichem Laboratories will announce their March quarter earnings on May 22.
